ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

ClinicalTrials.gov ID: NCT06234488

Public ClinicalTrials.gov record NCT06234488. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 5:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Institutional Retrospect Cohort Study of Breast Cancer Diagnosis and Management in Transgender and Gender-Diverse Individuals

Study identification

NCT ID
NCT06234488
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Medical College of Wisconsin
Other
Enrollment
125 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2023
Primary completion
Oct 31, 2024
Completion
Aug 29, 2026
Last update posted
Jan 11, 2026

2023 – 2026

United States locations

U.S. sites
22
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
University of Southern California/Los Angeles (USC/LA County) Los Angeles California 90089
University of California San Francisco (UCSF) San Francisco California 94115
University of Colorado Anschutz Medical Campus (CU Anschutz) Aurora Colorado 80045
MedStar Georgetown University Hospital (MGUH) Washington D.C. District of Columbia 20007
Mayo Clinic Jacksonville Florida 32224
Moffitt Cancer Center (MCC) Tampa Florida 33612
Northwestern Medicine Chicago Illinois 60611
Rush University Medical Center Chicago Illinois 60612
NorthShore University Health System Evanston Illinois 60201
Massachusetts General Hospital Boston Massachusetts 02114
Birgham and Women's Hospital Boston Massachusetts 02115
Boston University (Boston U) Boston Massachusetts 02118
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
New York University (NYU) New York New York 10012
University of Rochester Rochester New York 14623
Duke University Medical Center Durham North Carolina 27710
Cleveland Clinic Foundation (CCF) Cleveland Ohio 44195
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Vanderbilt University Medical Center (VUMC) Nashville Tennessee 37232
University of Washington (UW) Seattle Washington 98195
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06234488, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06234488 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →